Enhancing effect of the 145Met-allele of GPIb alpha on platelet sensitivity to aspirin under high-shear conditions

Thrombosis Research

Volumn 123, Issue 2, 2008, Pages 331-335

  Matsubara, Yumiko ^a   Murata, Mitsuru ^a   Watanabe, Gentaro ^b   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GLYCOPROTEIN IB ALPHA; METHIONINE;

ADULT; ALLELE; ARTICLE; DRUG EFFECT; DRUG SENSITIVITY; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SHEAR RATE; THROMBOCYTE;

ADULT; ALLELES; ASPIRIN; BLOOD PLATELETS; HUMANS; LOGISTIC MODELS; MALE; METHIONINE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; POLYMORPHISM, GENETIC; STRESS, MECHANICAL; VON WILLEBRAND FACTOR;

EID: 55549117156     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.02.008     Document Type: Article

References (18)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
2. Patrono C., Garcia Rodriguez L.A., Landolfi R., and Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 (2005) 2373-2383
3. Szczeklik A., Musial J., Undas A., and Sanak M. Aspirin resistance. J Thromb Haemost 3 (2005) 1655-1662
4. Andrews R.K., Gardiner E.E., Shen Y., Whisstock J.C., and Berndt M.C. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 35 (2003) 1170-1174
5. Aktas B., Pozgajova M., Bergmeier W., Sunnarborg S., Offermanns S., Lee D., et al. Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem 280 (2005) 39716-39722
6. Garcia A., Quinton T.M., Dorsam R.T., and Kunapuli S.P. Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets. Blood 106 (2005) 3410-3414
7. Yee D.L., and Bray P.F. Clinical and functional consequences of platelet membrane glycoprotein polymorphisms. Semin Thromb Hemost 30 (2004) 591-600
8. Macchi L., Christiaens L., Brabant S., Sorel N., Ragot S., Allal J., et al. Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms. J Am Coll Cardiol 42 (2003) 1115-1119
9. Douglas H., Davies G.J., Michaelides K., Gorog D.A., Timlin H., Ahmed N., et al. Detection of functional differences between different platelet membrane glycoprotein Ibalpha variable number tandem repeat and Kozak genotypes as shown by the PFA-100 system. Heart 92 (2006) 676-678
10. Williams M.S., Ng'alla L.S., and Vaidya D. Platelet functional implications of glycoprotein Ibalpha polymorphisms in African Americans. Am J Hematol 82 (2007) 15-22
11. Takahashi S., Ushida M., Komine R., Shimizu A., Uchida T., Ishihara H., et al. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin. Thromb Res 119 (2007) 517-524
12. Favaloro E.J. Clinical application of the PFA-100®. Curr Opin hematol 9 (2002) 407-415
13. Fontana P., Nolli S., Reber G., and de Moerloose P. Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. J Thromb Haemost 4 (2006) 813-819
14. Rozalski M., Boncler M., Luzak B., and Watala C. Genetic factors underlying differential blood platelet sensitivity to inhibitors. Pharmacol Rep 57 (2005) 1-13
15. Murata M., Matsubara Y., Kawano K., Zama T., Aoki N., Yoshino H., et al. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 96 (1997) 3281-3286
16. Ulrichts H., Vanhoorelbeke K., Cauwenberghs S., Vauterin S., Kroll H., Santoso S., et al. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol 23 (2003) 1302-1307
17. Matsubara Y., Murata M., Hayashi T., Suzuki K., Okamura Y., Handa M., et al. Platelet glycoprotein Ib alpha polymorphisms affect the interaction with von Willebrand factor under flow conditions. Br J Haematol 128 (2005) 533-539
18. Gardiner E.E., Karunakaran D., Shen Y., Arthur J.F., Andrews R.K., and Berndt M.C. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 5 (2007) 1530-1537